Chair: Edward J. Schutter; Executive Officer Roundtable & Summit Chair, GaBio; President and Chief Executive Officer, Arbor Pharmaceuticals
Charles Craig; President, Georgia Bio
Patricia A. Fritz MS RAC; Vice President, Policy and Communication, UCB, Inc.
Ross Mason; Founder, Healthcare Institute for Neuro-Recovery and Innovation (HINRI), Georgia
Margaret Poole; Chief Executive Officer, Informed Horizons
John "JJ" Spegele; Vice President, General Manager, Quintiles Laboratories North America
Maria Thacker; Director of Operations, Georgia Bio
Chair: John “JJ” Spegele; Vice President, General Manager, Quintiles Laboratories North & South America
Clay Fowler; Peach Seed Capital
Mark Gilreath; President and Chief Executive Officer, EndoChoice Inc.
Mark W. Hamrick; Interim Vice President for Research, Professor Department of Cellular Biology & Anatomy, Georgia Health Sciences University
Michael R. Hanley, Ph.D.; Chief Executive Officer, Celtaxsys, Inc
Barney Koszalka, PhD; President/Chief Executive Officer, NeurOp, Inc.
Dan Myers; President and Chief Executive Officer, Alimera Sciences, Inc
Robin Morris, Ph.D.; Associate Provost for Strategic Initiatives & Innovation, Georgia State University
Ed Perkins; Johnson & Johnson
Anthony J. Rotunno, Sr.; Vice President & General Manager, Dendreon Corporation
Suzanne S. Shope, J.D.; Technology Licensing and Marketing Scientist, Centers for Disease Control and Prevention
William “Bill” C. Taylor; President and Chief Operating Officer, MiMedx Group, Inc.
Andrew Watkins, JD, PhD; Director, Technology Transfer Office, Centers for Disease Control and Prevention